<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To test whether <z:chebi fb="11" ids="22586">antioxidant</z:chebi> treatment could prevent the progression of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: In a rat model of gastroduodenoesophageal reflux by esophagojejunal anastomosis with gastric preservation, groups of 6-10 rats were randomized to receive treatment with <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD) or vehicle and followed up for 4 mo </plain></SENT>
<SENT sid="2" pm="."><plain>Rat's esophagus was assessed by histological analysis, <z:chebi fb="1" ids="18421">superoxide</z:chebi> <z:chebi fb="5" ids="22563">anion</z:chebi> and peroxinitrite generation, SOD levels and DNA oxidative damage </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> rats undergoing esophagojejunostomy developed extensive esophageal mucosal ulceration and <z:mp ids='MP_0001845'>inflammation</z:mp> by mo 4 </plain></SENT>
<SENT sid="4" pm="."><plain>The process was associated with a progressive presence of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> beyond the anastomotic area (9% 1st mo and 50% 4th mo) (94% at the anastomotic level) and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (11% 1st mo and 60% 4th mo) </plain></SENT>
<SENT sid="5" pm="."><plain>These changes were associated with <z:chebi fb="1" ids="18421">superoxide</z:chebi> <z:chebi fb="5" ids="22563">anion</z:chebi> and peroxinitrite mucosal generation, an early and significant increase of DNA oxidative damage and a significant decrease in SOD levels (P&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Exogenous administration of SOD decreased mucosal <z:chebi fb="1" ids="18421">superoxide</z:chebi> levels, increased mucosal SOD levels and reduced the risk of developing <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> beyond the anastomotic area (odds ratio = 0.326; 95%CI: 0.108-0.981; P = 0.046), and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (odds ratio = 0.243; 95%CI: 0.073-0.804; P = 0.021) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: <z:chebi fb="1" ids="18421">Superoxide</z:chebi> dismutase prevents the progression of <z:hpo ids='HP_0100633'>esophagitis</z:hpo> to <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in this rat model of <z:e sem="disease" ids="C0599290" disease_type="Disease or Syndrome" abbrv="">gastrointestinal reflux</z:e>, supporting a role of <z:chebi fb="11" ids="22586">antioxidants</z:chebi> in the chemoprevention of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>